Reduction of elevated arterial blood pressure in obese Zucker rats by inhibition of ganglionic long-term poteniation

被引:25
作者
Gerges, NZ [1 ]
Aleisa, AM [1 ]
Alhaider, AA [1 ]
Alkadhi, KA [1 ]
机构
[1] Univ Houston, Dept Pharmacol & Pharmaceut Sci, Houston, TX 77204 USA
关键词
ondansetron; compound action potential; hypertension; superior cervical ganglion; Zucker rats; blood pressure; obesity; 5-HT3;
D O I
10.1016/S0028-3908(02)00283-6
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Sustained enhancement of the basal tone of ganglionic transmission is expected to result in an enduring increase in peripheral resistance that would lead to elevated blood pressure. Long-term potentiation of sympathetic ganglia is an activity-dependent long-lasting increase in strength of ganglionic transmission. Therefore, ganglionic long-term potentiation might be involved in the manifestation of neurogenic forms of hypertension. Expression of sympathetic ganglionic long-term potentiation is dependent on activation of 5-HT3 receptor. We examined the possibility that elevated blood pressure in obese Zucker rat, which is reported to be stress-prone, might be partly due to a neurogenic factor resulting from expression of ganglionic long-term potentiation. Chronic treatment with the 5-HT3 receptor antagonist ondansetron (0.5 mg/kg/day) caused a significant decrease in blood pressure of the obese Zucker rats without affecting that of normotensive lean Zucker rats. Electropysiological procedures to test for long-term potentiation in isolated ganglia suggest that ganglionic long-term potentiation has been previously expressed in vivo in ganglia from obese Zucker rat but not in those from the normotensive lean Zucker rats. The results indicate that expression of ganglionic long-term potentiation in sympathetic ganglia may be responsible for neurogenic increase in blood pressure, which contributes to the moderate hypertension often seen in the obese Zucker rats. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1070 / 1076
页数:7
相关论文
共 46 条
[1]  
Alkadhi KA, 1998, N-S ARCH PHARMACOL, V358, pR265
[2]   Inhibition of ganglionic long-term potentiation decreases blood pressure in spontaneously hypertensive rats [J].
Alkadhi, KA ;
Otoom, SA ;
Tanner, FL ;
Sockwell, D ;
Hogan, YH .
EXPERIMENTAL BIOLOGY AND MEDICINE, 2001, 226 (11) :1024-1030
[3]   Induction and maintenance of ganglionic long-term potentiation require activation of 5-hydroxytryptamine (5-HT3) receptors [J].
Alkadhi, KA ;
SalgadoCommissariat, D ;
Hogan, YH ;
Akpaudo, SB .
JOURNAL OF PHYSIOLOGY-LONDON, 1996, 496 (02) :479-489
[4]   Retrograde carbon monoxide is required for induction of long-term potentiation in rat superior cervical ganglion [J].
Alkadhi, KA ;
Al-Hijailan, RS ;
Malik, K ;
Hogan, YH .
JOURNAL OF NEUROSCIENCE, 2001, 21 (10) :3515-3520
[5]   Nitric oxide mediates long-term potentiation in rat superior cervical ganglion [J].
Alkadhi, KA ;
Altememi, GF .
BRAIN RESEARCH, 1997, 753 (02) :315-317
[6]   MODULATED LONG-TERM POTENTIATION IN THE CAT SUPERIOR CERVICAL-GANGLION INVIVO [J].
ALONSODEFLORIDA, F ;
MORALES, MA ;
MINZONI, AA .
BRAIN RESEARCH, 1991, 544 (02) :203-210
[7]   Hypertension in obese Zucker rats - Role of angiotensin II and adrenergic activity [J].
AlonsoGalicia, M ;
Brands, MW ;
Zappe, DH ;
Hall, JE .
HYPERTENSION, 1996, 28 (06) :1047-1054
[8]   Nitric oxide is required for the maintenance but not initiation of ganglionic long-term potentiation [J].
Altememi, GF ;
Alkadhi, KA .
NEUROSCIENCE, 1999, 94 (03) :897-902
[9]   EFFECTS OF CORTICOTROPIN RELEASING-FACTOR ON GENETICALLY-OBESE (FATTY) RATS [J].
ARASE, K ;
SHARGILL, NS ;
BRAY, GA .
PHYSIOLOGY & BEHAVIOR, 1989, 45 (03) :565-570
[10]   PREGANGLIONIC AXONS FROM THE 3RD THORACIC SPINAL SEGMENT FAIL TO INDUCE LONG-TERM POTENTIATION IN THE SUPERIOR CERVICAL-GANGLION OF THE CAT [J].
BACHOO, M ;
POLOSA, C .
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1992, 70 :S27-S31